2020
DOI: 10.21203/rs.3.rs-36602/v3
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

MCCMF: Collaborative matrix factorization based on matrix completion for predicting miRNA-disease associations

Abstract: Background: MicroRNAs (MiRNAs) are non-coding RNAs with regulatory functions. Many studies have shown that miRNAs are closely associated with human diseases. Among the methods to explore the relationship between the miRNA and the disease, traditional methods are time-consuming and the accuracy needs to be improved. In view of the shortcoming of previous models, a collaborative matrix factorization based on matrix completion (MCCMF) is proposed to predict the unknown miRNA-disease associations.Results: The comp… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 24 publications
(25 reference statements)
0
2
0
Order By: Relevance
“…Numerous methods have been designed to integrate additional information into MF-based techniques such as those based on Inductive Matrix Completion (Li et al, 2020(Li et al, , 2021, Graph-regularized Matrix Factorization (Zhang et al, 2020), and Collaborative Matrix Factorization (Wu et al, 2020). The typical setting in these methods comprises a central matrix containing known and unknown values of the association of interest (e.g., gene-disease or drug-target) and various ways of incorporating auxiliary data (as features or networks) of the entities of interest (genes and diseases, or drugs and targets) within the modeling framework used.…”
Section: Introductionmentioning
confidence: 99%
“…Numerous methods have been designed to integrate additional information into MF-based techniques such as those based on Inductive Matrix Completion (Li et al, 2020(Li et al, , 2021, Graph-regularized Matrix Factorization (Zhang et al, 2020), and Collaborative Matrix Factorization (Wu et al, 2020). The typical setting in these methods comprises a central matrix containing known and unknown values of the association of interest (e.g., gene-disease or drug-target) and various ways of incorporating auxiliary data (as features or networks) of the entities of interest (genes and diseases, or drugs and targets) within the modeling framework used.…”
Section: Introductionmentioning
confidence: 99%
“…This method builds the miRNA disease relationship into a matrix and decomposes the matrix. Wu et al [15] completes and optimizes the miRNA-disease adjacency matrix. They use the miRNA functional similarity matrix and the disease semantic similarity matrix and the KNN method to complete the miRNA-disease adjacency matrix.…”
Section: Introductionmentioning
confidence: 99%